Genetic Technologies Ltd. is a molecular diagnostics company that offers predictive testing and assessment to... More | Chart | Post
Full Profile of GENE (Genetic Technologies Limited) : Nasdaq
Market Cap: 19.67M | Industry: Health Care/Life Sciences
Genetic Technologies Ltd. is a molecular diagnostics company that offers predictive testing and assessment tools to help physicians proactively manage women's health. Its product, BREVAGenplus, is a clinically validated risk assessment test for non-hereditary breast...
Update on 52-wk highs for stocks under $15 on the NASDAQ: $DOTAR ⇑ at $0.60, $DOTAW ⇑ at $0.70, $KAACW ⇑ at $1.04, $RIBT ⇑ at $1.58 and $GENE ⇑ at $2.05.
Genetic Technologies Ltd. is a molecular diagnostics company that offers predictive testing and assessment tools to help physicians proactively manage women's health. Its product, BREVAGenplus, is a clinically validated risk assessment test for non-hereditary breast...